Neuroradiologic Correlates of Cognitive Impairment in Adult Moyamoya Disease

BACKGROUND AND PURPOSE: MMD has been shown to result in impairment of executive functioning in adults. The purpose of this study was to correlate presurgical neuropsychological assessments with the severity of primary MMD as measured by CBF and CVR and with secondary damage from MMD as estimated by cortical stroke and WMD. MATERIALS AND METHODS: A retrospective analysis of 31 adult patients with MMD was performed. Xe-CT was used to obtain CBF and CVR, and MRI was reviewed to grade cortical stroke and WMD. Two tests of executive functioning (FAS and TMT-B) were correlated with imaging findings. A multiple regression analysis was performed. RESULTS: There was a significant overall positive relationship between mean CBF and FAS (P = .038) and TMT-B scores (P = .014). A significant negative relationship was present between the WMD score and the FAS (P = .009) and TMT-B scores (P = .015). Per-region analysis demonstrated that FAS and TMT-B scores were significantly decreased by the presence of a posterior stroke (P < .0001 and P = .001) or WMD (P = .006 and P = .004). All patients with posterior parieto-occipital WMD or stroke also had secondary disease in the anterior regions. CONCLUSIONS: Impaired executive functioning in adults with MMD is most strongly associated secondary damage in the form of WMD or cortical stroke. The effect is most profound with parieto-occipital lobe involvement, likely a reflection of overall disease severity. Increasing global WMD burden may be a better indicator of cognitive decline than cortical infarction. Patients with higher baseline CBF seem to have better cognitive functioning.

[1]  P. Gritti,et al.  Decompressive surgery in malignant dural sinus thrombosis: report of 3 cases and review of the literature. , 2009, Neurosurgical focus.

[2]  M. Zuccarello,et al.  The Acetazolamide Challenge: Techniques and Applications in the Evaluation of Chronic Cerebral Ischemia , 2009, American Journal of Neuroradiology.

[3]  Greg Zaharchuk,et al.  Quantitative hemodynamic studies in moyamoya disease , 2009 .

[4]  Todd,et al.  Spinal extradural arteriovenous malformations with parenchymal drainage: venous drainage variability and implications in clinical manifestations. , 2009, Neurosurgical focus.

[5]  Nae-jung Rim,et al.  Which CT Perfusion Parameter Best Reflects Cerebrovascular Reserve?: Correlation of Acetazolamide-Challenged CT Perfusion with Single-Photon Emission CT in Moyamoya Patients , 2008, American Journal of Neuroradiology.

[6]  K. Nozaki,et al.  Autosomal dominant moyamoya disease maps to chromosome 17q25.3 , 2008, Neurology.

[7]  J. Roh,et al.  Changing ischaemic lesion patterns in adult moyamoya disease , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[8]  L. Dorfman,et al.  Effect of moyamoya disease on neuropsychological functioning in adults. , 2008, Neurosurgery.

[9]  J. Detre,et al.  Neuropsychological and perfusion MR imaging correlates of revascularization in a case of moyamoya syndrome. , 2006, AJNR. American journal of neuroradiology.

[10]  M. Aoyagi,et al.  Mental outcome following encephaloduroarteriosynangiosis in children with moyamoya disease with the onset earlier than 5 years of age , 1990, Child's Nervous System.

[11]  N. Tamaki,et al.  Chronic low-perfusion state in children with moyamoya disease following revascularization , 1990, Child's Nervous System.

[12]  Takashi Yoshimoto,et al.  Cerebrovascular Reactivity to Acetazolamide and Outcome in Patients With Symptomatic Internal Carotid or Middle Cerebral Artery Occlusion: A Xenon-133 Single-Photon Emission Computed Tomography Study , 2002, Stroke.

[13]  J. Gosalakkal Moyamoya disease: a review. , 2002, Neurology India.

[14]  Kiyohiro Houkin,et al.  Long-Term Prognosis of Medically Treated Patients With Internal Carotid or Middle Cerebral Artery Occlusion: Can Acetazolamide Test Predict It? , 2001, Stroke.

[15]  Toshihiro Tanaka,et al.  Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. , 2000, Stroke.

[16]  H. Touho,et al.  Preoperative and postoperative evaluation of cerebral perfusion and vasodilatory capacity with 99mTc-HMPAO SPECT and acetazolamide in childhood Moyamoya disease. , 1996, Stroke.

[17]  M. Fukui,et al.  Cerebral circulation and oxygen metabolism in childhood moyamoya disease: a perioperative positron emission tomography study. , 1994, Journal of neurosurgery.

[18]  S. Miyamoto,et al.  Study of the posterior circulation in moyamoya disease. Clinical and neuroradiological evaluation. , 1984, Journal of neurosurgery.

[19]  A Takaku,et al.  Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. , 1969, Archives of neurology.